Treating sexual desire disorders with flibanserin
US10098876B2 · kind B2 · utility
0Cited by
6References
20Claims
0Family size
Inventors
Key dates
| Filing date | Sep 1, 2017 |
| Grant date | Oct 16, 2018 |
| Priority date | — |
| Expiry date | Sep 1, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.